Fractionation and identification of antioxidant peptides from an enzymatically hydrolysed Palmaria palmata protein isolate by Harnedy, Pádraigín A. et al.
 1 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
Fractionation and identification of antioxidant peptides from an enzymatically 9 
hydrolysed Palmaria palmata protein isolate 10 
 11 
 12 
 13 
 14 
Pádraigín A. Harnedy, Martina B. O’Keeffe and Richard J. FitzGerald*  15 
Department of Biological Sciences, University of Limerick, Limerick, Ireland 16 
 17 
 18 
 19 
* Corresponding author: Tel: +35361202598; Fax: +35361331490 20 
Email address: Dick.Fitzgerald@ul.ie 21 
 22 
Padraigin.Harnedy@ul.ie 23 
Martina.OKeeffe@ul.ie 24 
 25 
 2 
Abstract  26 
Proteins derived from the macroalgal species Palmaria palmata have emerged as 27 
potential substrates for the generation of bioactive peptides. The aim of this study 28 
was to fractionate, identify and characterize antioxidant peptides from a P. 29 
palmata protein hydrolysate. The P. palmata protein hydrolysate generated with 30 
the food-grade proteolytic enzyme Corolase PP was sequentially fractionated 31 
using solid phase extraction and semi-preparative (SP) RP-HPLC. The most 32 
active SP-RP-HPLC peptide fraction (SP-RP-HPLC-30-F26) was analysed by 33 
ESI-MS/MS. Seventeen novel peptide sequences were identified in this fraction. 34 
Of the peptides selected for synthesis, Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Asn-35 
Met, showed the highest oxygen radical absorbance capacity (ORAC) and ferric 36 
reducing antioxidant power (FRAP) activity with values of 152.43 ± 2.73 and 37 
21.23 ± 0.90 nmol TE/µmol peptide, respectively. The results presented herein 38 
indicate that P. palmata derived peptides may have potential applications as 39 
health enhancing ingredients and as food preservatives due to their antioxidant 40 
activity. 41 
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1. Introduction 51 
An increase in the production of reactive oxygen species (ROS) in conjunction with an 52 
overload on endogenous antioxidant defence systems (enzymatic and non-enzymatic) 53 
has been implicated as a possible causative factor for the initiation and/or progression 54 
of many chronic diseases. These include cardiovascular disease (CVD), cancer, 55 
diabetes mellitus, cataracts and neurodegenerative disorders (Lobo, Patil, Phatak, & 56 
Chandra, 2010; Valko et al., 2007). Free radicals and other ROS are generated as part 57 
of the normal metabolic processes in the body. Furthermore, the body can also be 58 
exposed to external sources of free radicals such as x-rays, ozone, cigarette smoking, 59 
air pollutants and industrial chemicals. Through evolution, aerobic organisms have 60 
developed highly advanced enzymatic and non-enzymatic antioxidant defence systems 61 
to counteract free radicals. However, at times when the body’s metabolic 62 
oxidant/antioxidant equilibrium is altered (oxidative stress), excessive quantities of 63 
reactive radicals can cause cellular damage which, in turn, can initiate or promote many 64 
of the diseases listed above (Sarmadi & Ismail, 2010). With an increase in the 65 
prevalence of diseases where oxidative stress is believed to be a causative factor a need 66 
exists to identify natural antioxidant components with little or no adverse effects on 67 
health that may be used to combat oxidative damage within the body. Additionally, as 68 
there is increasing evidence linking synthetic antioxidants to negative health effects the 69 
food industry is looking for natural antioxidant components for application as 70 
alternative preservation agents in food products (Lobo et al., 2010; Shahidi & Zhong, 71 
2005). 72 
The beneficial effects of food-derived components, including peptides, in health 73 
promotion and disease prevention are being increasingly recognized. These short 74 
peptides, which in general range from 2-20 amino acids in size, are encrypted within 75 
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the primary sequence of the parent protein and become active when released during 76 
food processing (by enzymatic hydrolysis or fermentation) or during gastrointestinal 77 
transit (Harnedy & FitzGerald, 2012). A growing body of scientific literature indicates 78 
the potential of food protein-derived peptides as antioxidant agents to combat the 79 
deleterious effects associated with oxidative stress (Freitas et al., 2013; Power, 80 
Jakeman, & FitzGerald, 2013).  81 
Palmaria palmata (P. palmata), a red macroalgal species containing relatively high 82 
levels of protein (35% (w/w)) is a rich source of bioactive proteinaceous components 83 
(Harnedy & FitzGerald, 2013b). More specifically, a number of P. palmata derived 84 
protein isolates, protein hydrolysates, peptide fractions and mycosporine-like amino 85 
acids have shown promising antioxidant activity in vitro (Beaulieu, Sirois, & 86 
Tamigneaux, 2016; Bondu et al., 2014; Harnedy & FitzGerald, 2013b; Harnedy, Soler-87 
Vila, Edwards, & FitzGerald, 2014; Wang et al., 2010; Yuan, Bone, & Carrington, 88 
2005; Yuan, Carrington, & Walsh, 2005; Yuan, Westcott, Hu, & Kitts, 2009). Bondu 89 
et al. (2014) and Beaulieu et al. (2016) have identified numerous peptides in P. palmata 90 
protein hydrolysate fractions showing high antioxidant activity. It was found that the 91 
majority of the peptides identified originated from ribulose-1,5-biphosphate 92 
carboxylase/oxygenase (RuBisCO) and pigments such as allophycocyanin, 93 
phycoerythrin and phycocyanin. However, confirmatory studies with synthetic peptides 94 
were not performed to identify and confirm which of the peptides were potentially 95 
responsible for the observed antioxidant activity (Beaulieu et al., 2016; Bondu et al., 96 
2014). The objective of the study herein was to fractionate, identify and characterize 97 
peptides with antioxidant activity from a P. palmata protein hydrolysate. 98 
 99 
2. Materials and methods 100 
 5 
2.1 Materials 101 
Corolase PP was provided by AB Enzymes (Darmstadt, Germany) and BC pepsin was 102 
provided by Biocatalysts (Cardiff, United Kingdom). HPLC grade water and 103 
acetonitrile (ACN) were obtained from VWR International (Dublin, Ireland). ESI low 104 
molecular mass tune mix was from Agilent Technologies (Cork, Ireland). The synthetic 105 
peptides Ala-Asn-Ala-Ala-Thr-Ile-Ile-Lys, Asn-Ala-Ala-Thr-Ile-Ile-Lys, Leu-Gly-106 
Leu-Ser-Gly-Lys, Phe-Ile-Thr-Asp-Gly-Asn-Lys were obtained from Thermo Fisher 107 
Scientific (Ulm, Germany). The synthetic peptides Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-108 
Gln-Met, Asp-Asn-Ile-Gln-Gly-Ile-Thr-Lys-Pro-Ala, Leu-Ile-Thr-Gly-Ala,  Leu-Ile-109 
Thr-Gly-Ala-Ala,  Leu-Ile-Thr-Gly-Ala-Ala-Gln-Ala, Val-Val-Pro-Thr, Gln-Ala-Arg-110 
Gly-Ala-Ala-Gln-Ala, Leu-Thr-Leu-Ala-Pro-Lys, Leu-Thr-Ile-Ala-Pro-Lys, Ile-Thr-111 
Leu-Ala-Pro-Lys and Ile-Thr-Ile-Ala-Pro-Lys were from GenScript (Piscataway, NJ). 112 
All other reagents were supplied by Sigma Chemical Company Ltd. (Wicklow, 113 
Ireland). 114 
 115 
2.2 Sample preparation 116 
P. palmata samples were collected at Spiddal Beach, Co. Galway, Ireland. Of the total 117 
quantity of sample utilized in the study 75% was collected in March 2013 and 25% in 118 
May 2013. Following harvesting, the seaweed was washed with filtered seawater to 119 
remove sand and epiphytes. The cleaned seaweed was freeze-dried, mixed and 120 
pulverized with a Cyclotec™ Mill (1 mm screen, FOSS Tecator AB, Hoganas, Sweden) 121 
and stored in an air tight container at room temperature.  122 
 123 
2.3 Generation of P. palmata protein isolate and associated hydrolysate 124 
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Crude aqueous soluble protein isolates were extracted using the method previously 125 
described (Harnedy & FitzGerald, 2013b). In brief, 845g of the milled freeze-dried 126 
seaweed was suspended in 16.9 L de-ionised H2O (1:20 (w/v)) and mixed gently for 3 127 
h at room temperature. The seaweed suspension was centrifuged at 4,190 x g (Sorvall 128 
RC6 Plus, Fisher Scientific, Dublin, Ireland) for 15 min at room temperature and the 129 
supernatant retained. Aqueous soluble proteins in the supernatant were precipitated by 130 
isoelectric precipitation at pH 3.5 using 1.0 M HCl. The precipitated protein was 131 
resuspended in dH20 to a protein concentration of ~ 2.5% (w/v). The protein content of 132 
the crude aqueous soluble protein isolates was determined using the modified Lowry 133 
protein quantification method previously described (Harnedy & FitzGerald, 2013a). 134 
Bovine serum albumin was used to prepare a protein standard curve in the range 0-200 135 
μg/ml.  136 
The aqueous protein hydrolysate was generated with Corolase PP. A 2% (w/v) protein 137 
solution was adjusted to pH 7.0 with 1M NaOH and preheated to 50 °C prior to addition 138 
of the enzyme at an enzyme:substrate (E:S) ratio of 1% (w/w). The hydrolysis reaction 139 
was maintained at pH 7.0 using a pH-stat (842 Titrando, Metrohm, Switzerland). The 140 
enzyme was inactivated after 240 min by thermal inactivation at 90 oC for 20 min and 141 
the hydrolysate sample was subsequently freeze-dried (FreeZone 18L, Labconco, MO, 142 
USA) and stored at -20 oC. 143 
 144 
2.4 Fractionation of the aqueous P. palmata protein hydrolysate 145 
The aqueous P. palmata protein hydrolysate was fractionated using solid phase 146 
extraction (SPE) followed by semi-preparative reverse phase-high performance liquid 147 
chromatography (SP-RP-HPLC) as previously described (Harnedy, O’Keeffe, & 148 
FitzGerald, 2015). A 1% (w/v) protein hydrolysate (in HPLC-grade H2O) solution was 149 
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applied to a pre-activated SPE column (Strata-X 5g/60mL C18, Phenomenex, Cheshire, 150 
UK). Material that passed through the column was termed ‘unbound material’. Peptide 151 
fractions were sequentially eluted from the column using 10 ml HPLC grade H2O and 152 
10, 20, 25, 30, 40 and 60% (v/v) ACN. This was repeated 10 times and the individual 153 
fractions from each of the runs were pooled and dried using a solvent evaporator 154 
(Genevac, EZ-2 Plus, Genevac Ltd., Ipswich, UK). SP-RP-HPLC was utilized to further 155 
fractionate SPE-30% (the SPE peptide fraction that eluted at 30% (v/v) ACN). The dry 156 
SPE fractions were reconstituted at a concentration of 15 mg/ml (dw) in 0.1% (v/v) 157 
formic acid (FA) in HPLC grade H2O (Mobile Phase A) and a 500 µL aliquot was 158 
injected onto a column (Jupiter C18, 250 × 15 mm ID, 10 mm particle size, 300Å pore 159 
size) fitted with a C18 guard column (10 × 10 mm ID, Phenomenex Cheshire, UK) 160 
which was connected to a Waters SP-HPLC (Waters, Dublin, Ireland). Mobile phase B 161 
consisted of 80% (v/v) ACN containing 0.1% (v/v) FA. The flow rate was set at 162 
5 ml/min and the peptides were separated using the following gradient: 0–10 min: 0% 163 
B; 10–15 min: 0-18% B; 15-76 min: 18-60% B; 76-81 min: 60-100% B; 81-86 min: 164 
100% B; 86-91 min: 100-0% B; 91–96 min 0% B. The absorbance of the eluent was 165 
monitored at 214 nm. Fractions eluting from 20 – 60 min were collected every minute 166 
using a fraction collector (Waters, Dublin, Ireland). Individual 1 min fractions from 167 
multiple runs were pooled and dried using a solvent evaporator. 168 
 169 
2.5 Identification of peptides by UPLC-ESI-MS/MS 170 
The separation and identification of peptides in the most active semi-preparative RP-171 
HPLC fraction, SP-RP-HPLC-30-F26, was performed as previously described 172 
(Harnedy et al., 2015; O'Keeffe & FitzGerald, 2015). In brief, a 7 µl aliquot of a 1 173 
mg/ml solution of the fraction prepared in mobile phase A (0.1% FA in MS grade H2O), 174 
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was injected onto an ACQUITY BEH 300 C18 RP column (2.1 x 50 mm, 1.7 μm; 175 
Waters, Dublin, Ireland) connected to an ACQUITY UPLC (Waters, Dublin, Ireland). 176 
Mobile phase B was 0.1% FA in 80% (v/v) ACN. Peptides were separated as follows: 177 
0–1 min: 0% B; 1-2 min: 0-6% B; 2-52 min: 6-25% B; 52-53 min: 25-100% B; 53-178 
58 min: 100-50% B; 58-63 min: 50-0% B; 63-68 min: 0% B at a flow rate of 0.2 ml/min 179 
and monitored at 214 and 280 nm. MS analysis was performed on a micrOTOF Q II 180 
mass spectrometer (Bruker Daltonics, Bremen, Germany) in positive ion mode and full 181 
scans were carried out for Auto MS/MS between 100-2500 m/z. The MS/MS settings 182 
were as follows: capillary voltage 4500V; nebuliser pressure 1.8 Bar; dry gas flow 8 183 
L/min; dry gas temp, 220 ˚C; collision energy, 10 eV; collision cell RF 350 Vpp, 184 
transfer time 120 µs. PEAKS Studio 6.0 software (Bioinformatics Solutions Inc, 185 
Waterloo, Canada) was used to search all MS/MS spectra on the Mascot search engine 186 
against the SwissProt Eukaryota database. Homology analysis to macro- and micro-187 
algal protein sequences in an in-house database was used to generate de novo sequences 188 
and all peptide sequences determined were manually confirmed using the Annotate tool 189 
of Data Analysis software (Bruker Daltonics). 190 
All peptides showing homology to macroalgal proteins were chemically synthesized. 191 
The synthetic peptide, Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Asn-Met, and the 192 
corresponding peptide fractions generated following simulated gastrointestinal 193 
digestion (SGID,7µl of 0.005 mg ml-1 in mobile phase A (0.1% formic acid (FA) in 194 
MS-grade H2O) were separated and identified using an Acquity UPLC (Waters, Dublin, 195 
Ireland) coupled to an Impact HD Ultra high resolution (UHR) Q-TOF (Bruker 196 
Daltonics, Bremen, Germany). The MS/MS methods for long and short peptides were 197 
as previously published in O'Keeffe and FitzGerald (2015) and O'Keeffe, Norris, 198 
Alashi, Aluko, and FitzGerald (2017). The MS was calibrated with ESI tune mix 199 
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(Agilent) for the long peptide method and with sodium formate for the short peptide 200 
method. Masses of peptides expected to be generated following in silico peptic and 201 
Corolase PP digestion (BIOPEP: 202 
http://www.uwm.edu.pl/biochemia/index.php/en/biopep: using ‘pepsin pH1.3’ enzyme 203 
selection for in silico peptic digestion and ‘elastase (Type 1), chymotrypsin C, trypsin 204 
and combinations thereof’ for in silico Corolase PP digestion) were inserted on an 205 
include list in OTOF Control (Bruker Daltonics) such that these masses were 206 
preferentially fragmented in the MS. 207 
 208 
2.6 Simulated gastrointestinal digestion (SGID)  209 
The synthetic peptide showing high antioxidant activity was subjected to SGID by the 210 
method described previously (Harnedy et al., 2015; Walsh et al., 2004). In brief, 211 
peptides at a concentration of 20 mM were incubated at 37 ˚C and pH 2 for 90 min with 212 
pepsin at an enzyme:substrate ratio of 2.5% (w/w). A sub-sample representing 213 
simulated gastric digestion was removed and heat inactivated at 90 ˚C for 20 min. The 214 
remainder of the reaction mixture was adjusted to pH 7.5 using 1M NaOH and 215 
incubated for a further 150 min at 37 ˚C with Corolase PP (enzyme:substrate ratio of 216 
1% (w/w)). This simulated gastrointestinal digestion sample was inactivated as 217 
described above. All samples were stored at 4 ˚C prior to antioxidant activity 218 
assessment. 219 
 220 
2.7 Antioxidant activity 221 
Antioxidant activity was determined in vitro using the oxygen radical absorbance 222 
capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays as previously 223 
described (Harnedy & FitzGerald, 2013b). The ORAC and FRAP values were 224 
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expressed as μmol of Trolox equivalents per gram dry weight (μmol TE/g dw) for the 225 
unhydrolysed protein extract, the protein hydrolysate, the SPE- and the SP-RP-HPLC- 226 
fractions. The ORAC and FRAP antioxidant activities of the synthetic peptides were 227 
expressed as nmol TE/µmol peptide. All results were presented as mean ± standard 228 
deviation of independent triplicate analyses (n=3). 229 
 230 
2.8 Statistical analysis 231 
All statistical analysis was performed using the statistical software program SPSS 232 
(Version 22, IBM Inc., Chicago, IL, USA). Statistical significance at a level of p<0.05 233 
was determined using one-way analysis of variance (ANOVA) followed by Tukey’s 234 
and Games–Howell post-hoc tests, where applicable.  235 
 236 
3. Results and Discussion 237 
3.1 Bioassay-guided fractionation of antioxidant peptides from the P. palmata 238 
protein hydrolysate 239 
In a previous study we have shown that a P. palmata protein hydrolysate generated 240 
from the aqueous soluble protein fraction with the proteolytic enzyme preparation 241 
Corolase PP displayed high ORAC and FRAP antioxidant activity (Harnedy & 242 
FitzGerald, 2013b). The hydrolysate generated in a similar manner in this study from a 243 
newly harvested macroalgal sample with an extent of hydrolysis of 29.58 mg amino 244 
group g-1 protein showed similar ORAC (Table 1, 483.68 ± 31.09 µmol TE/g dw) and 245 
FRAP (Table 1, 25.29 ± 0.66 µmol TE/g dw) values to those previously reported which 246 
were 467.54 ± 26.73 and 21.59  ± 0.55 µmol TE/g dw for ORAC and FRAP antioxidant 247 
activity, respectively (Harnedy & FitzGerald, 2013b). While the antioxidant activity of 248 
P. palmata protein hydrolysates generated with a range of proteolytic enzymes have 249 
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been reported, the identity of the peptide sequences potentially responsible for the 250 
observed antioxidant activity in these  hydrolysates have not been identified (Beaulieu 251 
et al., 2016; Bondu et al., 2014; Harnedy & FitzGerald, 2013b; Harnedy et al., 2014; 252 
Wang et al., 2010).  253 
In this study, peptides were separated based on their hydrophobic properties using RP 254 
C18 SPE cartridges followed by semi-preparative RP-HPLC. As shown in Table 1, the 255 
antioxidant activities of peptide fractions eluted with ACN were significantly higher 256 
than the unbound peptide fraction and the peptide fraction eluted with H2O. 257 
Furthermore, the ORAC and FRAP values recorded for the hydrophobic fractions, with 258 
the exception of the peptide fraction eluted with 20% (v/v) ACN, were significantly 259 
higher than those observed for the unfractionated hydrolysate. The highest ORAC 260 
activity was recorded with the peptide fractions eluted with 25, 30, 40% (v/v) ACN 261 
(Table 1), while the highest FRAP activity was observed with the peptide fractions 262 
eluted with 30 and 40% (v/v) ACN (Table 1). The SPE fraction eluted with 30% (v/v) 263 
ACN was selected for further fractionation as insufficient material was recovered 264 
following elution with 40% (v/v) ACN. 265 
The SP-RP-HPLC profile of SPE-30% and the associated ORAC activity of the 266 
lyophilized RP fractions taken therefrom between 20 and 60 min (F20-F60) are shown 267 
in Fig 1. Fraction 26, the peptide fraction eluting at 26 min displayed significantly 268 
higher ORAC activity than all other fractions (Fig 1, 4380.75 ± 66.44 µmol TE/g dw). 269 
With the exception of F26, the quantity of material recovered following semi-270 
preparative RP-HPLC fractionation was too low to perform FRAP analysis. A FRAP 271 
value of 51.86 ± 1.85 µmol TE/g dw was obtained for F26. This value was lower than 272 
that obtained for SPE-30%, the fraction from which it arose (Table 1, 110.35 ± 2.63 273 
µmol TE/g dw). It is possible that one of the other SP-RP-HPLC fractions may have 274 
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higher FRAP activity or that the high FRAP activity seen in SPE-30% was a result of a 275 
mixture of peptides from different fractions mediating a synergistic effect. 276 
 277 
3.2 Identification of P. palmata derived antioxidant peptides 278 
Mass spectrometry (MS) analysis was performed on SP-RP-HPLC-30-F26 in an 279 
attempt to identify the peptides potentially associated with the observed antioxidant 280 
activity. This was performed using a database (Swiss-Prot) driven search approach and 281 
by de novo sequencing. Table 2 provides a list of all the peptides identified in SP-RP-282 
HPLC-30-F26 and Fig. 2 is a representative mass spectrum for Ser-Asp-Ile-Thr-Arg-283 
Pro-Gly-Gly-Gln-Met. Eleven of the seventeen peptide sequences identified were 284 
homologous to available macroalgal protein sequences. These include Phe-Ile-Thr-285 
Asp-Gly-Asn-Lys, Asn-Ala-Ala-Thr-Ile-Ile-Lys, Ala-Asn-Ala-Ala-Thr-Ile-Ile-Lys, 286 
Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met, Asp-Asn-Ile-Gln-Gly-Ile-Thr-Lys-Pro-287 
Ala, Leu-Ile-Thr-Gly-Ala, Leu-Ile-Thr-Gly-Ala-Ala, Leu-Ile-Thr-Gly-Ala-Ala-Gln-288 
Ala, Leu-Gly-Leu-Ser-Gly-Lys, Leu/Ile-Thr-Leu/Ile-Ala-Pro-Lys and Val-Val-Pro-289 
Thr. The majority of the peptides identified in this fraction originated from pigment 290 
proteins such as allophycocyanin, phycoerythrin and phycocyanin. This was also seen 291 
in the studies performed by Bondu et al. (2014) and Beaulieu et al. (2016) where the 292 
highest number of peptides identified in their P. palmata hydrolysate subfractions 293 
showing high antioxidant activity were from pigment proteins. In addition, Bondu et al. 294 
(2014) and Beaulieu et al. Beaulieu et al. (2016) reported that a large number of the 295 
peptides identified in the active sub-fractions were from the sequence of RuBisCO, an 296 
enzyme involved in photosynthesis. In contrast, only one peptide identified in this study 297 
originated from this metabolic plant enzyme.  298 
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Of the eleven peptides originating from macroalgal proteins, six were homologous to 299 
protein sequences from Rhodophyta species that have been confirmed on a protein level 300 
(Asn-Ala-Ala-Thr-Ile-Ile-Lys, Ala-Asn-Ala-Ala-Thr-Ile-Ile-Lys, Leu-Ile-Thr-Gly-301 
Ala, Leu-Ile-Thr-Gly-Ala-Ala, Leu-Ile-Thr-Gly-Ala-Ala-Gln-Ala and Leu-Gly-Leu-302 
Ser-Gly-Lys) and one peptide (Asp-Asn-Ile-Gln-Gly-Ile-Thr-Lys-Pro-Ala) where the 303 
protein sequence has been confirmed at transcription level. The latter peptide  is 304 
homologous to Griffithsia japonica Histone H4 protein (Q7XY85). Four of the eleven 305 
peptide sequences are homologous to red macroalgal protein sequences that have only 306 
been inferred from homology. In this instance the protein sequence can be predicted 307 
because clear orthologs exist in closely related species.  308 
Phe-Ile-Thr-Asp-Gly-Asn-Lys and Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met are 309 
homologous to P. palmata phycoerythrin beta chain (F2ZAL7) and allophycocyanin 310 
beta chain (M1VJV1), respectively. With the exception of the Thr residue, all amino 311 
acid residues in Phe-Ile-Thr-Asp-Gly-Asn-Lys are highly conserved in the 312 
phycoerythrin beta chain of other red macroalgal species, Porphyridium purpureum 313 
(P11393), Porphyridium sordidum (P29948), Rhodella violacea (Q02037), 314 
Polysiphonia urceolata (P84862), Gracilaria chilensis (Q7SIF), Griffithsia monilis 315 
(O36004) and Polysiphonia boldii (Q01922), all of which have been confirmed on a 316 
protein level. The Thr residue is replaced with Ala, Asn, or Ser in these macroalgal 317 
species and it may be possible that the sequence in P. palmata is Phe-Ile-Thr-Asp-Gly-318 
Asn-Lys and that a one codon difference at a genetic level translates to Thr as opposed 319 
to Ala, Asn or Ser. The peptide sequence Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met 320 
is conserved as Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Asn-Met in Porphyra yezoensis 321 
(P59857) and Galdieria sulphuraria (P00319) allophycocyanin beta chain. Both 322 
sequences are evident on a protein level. Again, it may be possible that a one codon 323 
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difference at a genetic level translates to a Gln in P. palmata allophycocyanin beta chain 324 
as opposed to Asn. The peptide sequence Leu/Ile-Thr-Leu/Ile-Ala-Pro-Lys is conserved 325 
as Leu-Thr-Ile-Ala-Pro-Lys in two red macroalgal transaldolase protein sequences. 326 
However, Galdieria sulphuraria (M2Y2Z5) and Chondrus crispus (R7QKU4) 327 
transaldolase sequences are only inferred from homology. Therefore, because the 328 
protein sequences have not been confirmed on a protein level and as no experimental 329 
evidence exists on a transcription level it is difficult to confirm whether the first and 330 
third residues are Ile or Leu. The tetra peptide Val-Val-Pro-Thr is found in a number of 331 
red macroalgal protein sequences. However, all of these sequences are only inferred 332 
from homology.  333 
To the best of our knowledge, none of peptides identified in this study, with the 334 
exception of Leu-Gly-Leu-Ser-Gly-Lys have previously been reported in the literature. 335 
The pentapeptide Leu-Gly-Leu-Ser-Gly which is similar to Leu-Gly-Leu-Ser-Gly-Lys 336 
was previously identified in a P. palmata derived SP-RP-HPLC peptide fraction 337 
showing high DPP-IV inhibitory activity (Harnedy et al., 2015). Furthermore, a similar 338 
peptide, Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Asn-Met-Tyr, to the peptide identified in 339 
this study (Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met) has previously been identified 340 
in a fraction showing high antioxidant activity (Beaulieu et al., 2016). However, the 341 
sequence of this peptide was identified from the P. palmata allophycocyanin beta chain 342 
sequence which is only inferred from homology. In the current study the penultimate 343 
C-terminal residue was identified as Gln as opposed to Asn (Fig 2) which suggests that 344 
Asn is not conserved at this position in the allophycocyanin beta chain sequence of all 345 
Rhodophyta species. 346 
 347 
3.3 Antioxidant activity of selected synthetic peptides. 348 
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In an attempt to identify the peptide(s) potentially responsible for the observed 349 
antioxidant activity in the active SP-RP-HPLC peptide fraction, all peptides showing 350 
homology to macroalgal proteins were chemically synthesised and assessed for peroxyl 351 
radical scavenging and ferric ion reducing activity. As shown in Table 3 the peptide, 352 
Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met, displayed significantly higher ORAC and 353 
FRAP activity than all other peptides with values of 152.43 ± 2.73 and 21.23 ± 0.90 354 
nmol TE/µmol peptide obtained, respectively.  355 
The structure-activity relationship of antioxidant peptides has not yet been fully 356 
elucidated. However, the length of the peptide (3-16 amino acids), the presence of 357 
aromatic amino acids such as Tyr, His, Trp, and Phe and hydrophobic amino acids 358 
including Val, Leu, Ile, Pro, Ala, Met and Gly within a peptide, along with the structure 359 
at the C- and N- terminal residue is believed to influence antioxidant activity (Wang, 360 
Zhao, & Wang, 2013; Zou, He, Li, Tang, & Xia, 2016). Therefore, it is possible that 361 
the antioxidant activity observed with Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met may 362 
be associated with the presence of Ile, Pro, Gly and Met residues within its sequence. 363 
According to structure-activity relationship studies performed with quantitative 364 
structure–activity relationship (QSAR) modelling the presence of bulky hydrophobic 365 
amino acids at the C-terminal region, in particular at position C3, is believed to 366 
influence the peroxyl radical scavenging activity of peptides (Li & Li, 2013). However, 367 
Asn-Ala-Ala-Thr-Ile-Ile-Lys and Ala-Asn-Ala-Ala-Thr-Ile-Ile-Lys which contain Ile at 368 
C3, were shown to have low activity (Table 3). It is possible that the absence of other 369 
key residues, i.e., aromatic amino acids, within the sequence may have contributed to 370 
the low antioxidant potency observed. The result of a chemometric multivariate 371 
analysis study identified amino acid composition as a significant contributor to FRAP 372 
activity and in particular it was found that sulphur-containing amino acids such as Cys 373 
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and Met are the most potent at reducing the Fe3+-2,4,6-tripyridyl-S-triazine complex 374 
(Udenigwe & Aluko, 2011). Therefore, it may be possible that the high FRAP value 375 
observed with Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met may be due to the Met 376 
residue. It was proposed that the positive contribution of Met to FRAP antioxidant 377 
activity is due to its sulphur group, which is prone to oxidation by the reactive species 378 
(Udenigwe & Aluko, 2011). Other amino acid residues such as Cys, Glu, Gln, Asp, 379 
Asn, Thr and Gly are also believed to contribute to ferric reducing power while Lys 380 
was shown to have a highly negative effect on FRAP activity (Udenigwe & Aluko, 381 
2011). Interestingly, nine of the thirteen peptides with FRAP activity <1.6 nmol 382 
TE/µmol peptide contain a Lys residue with eight of these found at the peptide’s C 383 
terminus. In addition, it may be possible that the 3-D structure of a peptide could impact 384 
on antioxidant activity; however, this was not investigated as part of this study. There 385 
is limited information in relation to the FRAP activity of synthetic peptides, however, 386 
the ORAC value recorded for Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met, the peptide 387 
showing highest activity (Table 3, 152.43 ± 2.73 nmol TE/µmol peptide (0.152 ± 0.003 388 
µmol TE/µmol peptide) was lower than the ORAC values reported for antioxidant 389 
peptides identified from milk and egg white proteins (0.306-0.799 µmol TE/µmol 390 
peptide, Hernández-Ledesma, Dávalos, Bartolomé, & Amigo, 2005; López-Expósito, 391 
Quirós, Amigo, & Reci, 2007; Nimalaratne, Bandara, & Wu, 2015). This activity was 392 
significantly lower than antioxidant peptides mined from β-lactoglobulin, κ-casein, 393 
ovotransferrin, peanut, walnut  and egg white protein where ORAC values in the range 394 
of 1.240-15.470 µmol TE/µmol peptide were reported (Chen et al., 2015; Dávalos, 395 
Miguel, Bartolomé, & López-Fandiño, 2004; Hernández-Ledesma et al., 2005; López-396 
Expósito et al., 2007; Nimalaratne et al., 2015; Power, Fernández, Norris, Riera, & 397 
FitzGerald, 2014; Shen, Chahal, Majumder, You, & Wu, 2010; Zheng et al., 2012). 398 
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However, to the best of our knowledge, this is the first report of a peptide exhibiting 399 
both peroxyl radical scavenging and ferric ion reducing activity. 400 
In vitro digestion studies are often employed to assess the potential stability of a 401 
bioactive peptide as it passes through the gastrointestinal tract. Therefore, Ser-Asp-Ile-402 
Thr-Arg-Pro-Gly-Gly-Gln-Met which exhibited high antioxidant activity was subjected 403 
to SGID. As shown in Table 4 no significant difference in both ORAC and FRAP 404 
activity was observed with Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met during 405 
simulated gastric digestion. This was confirmed by MS analysis where Ser-Asp-Ile-406 
Thr-Arg-Pro-Gly-Gly-Gln-Met remained intact during incubation with pepsin (Table 407 
4). However, significantly lower ORAC (125.35 ± 2.04 nmol TE/µmol peptide) and 408 
FRAP (2.18 ± 0.07 nmol TE/µmol peptide) activity was observed following simulated 409 
intestinal digestion. Six peptides, Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln, Ser-Asp-Ile-410 
Thr-Arg-Pro-Gly-Gly, Ser-Asp-Ile-Thr, Pro-Gly-Gly-Gln, Ser-Asp, and Gln-Met and 411 
Met were generated during simulated intestinal digestion (Table 4). While information 412 
in relation to the structure-activity relationship of peptides exhibiting ORAC activity is 413 
limited, there is little or no information with regard to the effect of peptide structure on 414 
FRAP activity. Therefore, it is difficult to predict which amino acid residues or 415 
combinations of amino acid residues in the peptide are associated with the observed 416 
activity without performing confirmation studies on the peptide fragments/amino acids 417 
generated by the action of Corolase PP. However, overall a more pronounced negative 418 
effect on FRAP activity was observed following gastrointestinal digestion of the 419 
peptide than that observed with ORAC activity.  420 
  421 
4. Conclusions 422 
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In the present study a novel decapeptide, Ser-Asp-Ile-Thr-Arg-Pro-Gly-Gly-Gln-Met, 423 
with antioxidant activity was identified from an aqueous P. palmata protein 424 
hydrolysate. The results presented herein indicate that a P. palmata derived peptide or 425 
protein hydrolysate, which contains a complex mixture of peptides, may be a good 426 
source of antioxidant peptides for food and nutraceutical applications. However, it is 427 
necessary to perform further studies to investigate the ability of the protein 428 
hydrolysate/peptides to exhibit antioxidant activity in lipophilic systems, which is 429 
important both in a biological and food context. Furthermore, if the macroalgal-derived 430 
protein hydrolysate/peptide is to be utilized as an agent to combat oxidative stress, 431 
measures would need to be taken to protect the active components during intestinal 432 
digestion. Ultimately, a greater understanding of the biological fate of antioxidant 433 
peptides, where the efficacy of such peptides is confirmed in acute and long term in 434 
vivo studies, is required. 435 
 436 
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Table 1. Oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant 575 
power (FRAP) values of the Palmaria palmata aqueous protein extract, its hydrolysate 576 
and solid phase extraction fractions.  577 
Sample ORAC value 
(µmol TE/g dw) 
FRAP value 
(µmol TE/g dw) 
Unhydrolysed protein 69.28 ± 3.10 f 4.31 ± 0.08 e 
Hydrolysate 483.68 ± 31.09 cd 25.29 ± 0.66 c 
Unbound 241.25 ± 16.39 e 10.53 ± 0.24 d 
H2O wash 439.24 ± 31.13 
d 12.66 ± 0.62 d 
10% ACN 853.45 ± 43.01 a 64.37 ± 4.32 b 
20% ACN 584.40 ± 21.02 bc 36.73 ± 2.97 c 
25% ACN 1041.73 ± 67.88 a 64.26± 4.84 b 
30% ACN 971.84 ± 9.08 a 110.35 ± 2.63 a 
40% ACN 995.81 ± 55.25 a 137.95 ± 6.98 a 
60% ACN 770.79 ± 53.34 ab 63.47 ± 4.74 b 
Mean ± SD (n=3). Values with different letters are significantly different at p<0.05, 578 
TE: Trolox equivalents, dw: dry weight, ACN: Acetonitrile 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
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Table 2. Peptides identified (with flanking N and C terminal residues) in the Palmaria palmata aqueous protein extract hydrolysate semi-preparative 590 
reverse phase high performance liquid chromatography SP-RP-HPLC-30-F26.  591 
Peptide sequence Homologous to: Mass (m/z) Z Mass Error 
(Da) 
 Rhodophyta species showing 
100% homology (accession 
number) 
Protein    
K. FITDGNK. R Palmaria palmata a (F2ZAL7) Phycoerythrin beta chain 397.7031 2 0.0021 
A. NAATIIK. E Porphyra yezoensis (P59857) Allophycocyanin beta chain 365.7299 2 -0.0034 
A. ANAATIIK. E Porphyra yezoensis (P59857) Allophycocyanin beta chain 401.2393 2 0.0057 
Y.SDITRPGGQM.Y Palmaria palmata a (M1VJV1) Allophycocyanin beta chain 531.2532 2 0.0026 
R.DNIQGITKPA.I Griffithsia japonicab (Q7XY85) Histone H4 528.7837 2 0.0041 
R. LITGA. A Porphyridium purpureum (P37207) Phycocyanin alpha chain 474.3021 1 -0.0099 
R. LITGAA. Q Porphyridium purpureum (P37207) Phycocyanin alpha chain 545.3497 1 -0.0204 
R. LITGAAQA. V Porphyridium purpureum (P37207) Phycocyanin alpha chain 372.7164 2 -0.0030 
K. LGLSGK. N Galdieria sulphuraria (P23755) Ribulose bisphosphate carboxylase large chain 287.6778 2 0.0038 
R. L/ITL/IAPK. F Galdieria sulphurariaa (M2Y2Z5) 
Chondrus crispusa (R7QKU4) 
Transaldolase 321.7124 2 0.0026 
VVPT Multiple Rhodophyta speciesa Multiple protein sequences 415.2646 1 -0.0095 
QARGAAQA - - 772.4042 1 0.0018 
FML/IPDAHGL/ITM - - 616.8156 2 -0.0219 
SDL/ITRPNAGFYT - - 671.2998 2 0.0255 
L/IL/IASAA - - 545.3484 1 -0.0190 
L/ISHL/IAGV - - 348.7183 2 -0.0128 
TAL/IVPR - - 328.7056 2 -0.0250 
a Peptide sequence not evident at protein level, bExperimental evidence at transcript level, -: no homology with algal protein sequences 592 
 593 
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Table 3. Oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant 594 
power (FRAP) values of synthetic peptides. 595 
Peptide ORAC value 
(nmol TE/µmol peptide) 
FRAP value 
(nmol TE/µmol peptide) 
FITDGNK      5.79 ± 0.47cd 0.30 ± 0.02ef 
NAATIIK      3.70 ± 0.19f 0.16 ± 0.02g 
ANAATIIK    9.42  ± 0.60b 0.20  ± 0.02fg 
SDITRPGGQM   152.43 ± 2.73a 21.23 ± 0.90a 
DNIQGITKPA    5.08 ± 0.12de 0.69 ± 0.06e 
LITGA        1.94 ± 0.10h 0.14 ± 0.02g 
LITGAA     1.08 ± 0.10i 4.20 ± 0.08b 
LITGAAQA   5.91 ± 0.08c 0.57 ± 0.05e 
LGLSGK     4.82 ± 0.13e 1.26 ± 0.06d 
LTLAPK  nd 0.26 ± 0.05fg 
LTIAPK   2.99 ± 0.13fg 0.30 ± 0.01ef 
ITLAPK   4.43 ± 0.14e 1.59 ± 0.03c 
ITIAPK   1.61 ± 0.08hi 1.17 ± 0.02d 
VVPT   0.33 ± 0.08j 0.18 ± 0.01g 
QARGAAQA   2.82 ± 0.02g 0.26 ± 0.02fg 
 596 
Mean ± SD (n=3). Values with different letters are significantly different at p<0.05, 597 
TE: Trolox equivalents. nd: no activity detected 598 
 599 
 600 
 601 
 602 
 603 
 604 
 605 
 606 
 607 
 608 
 609 
 610 
 611 
 612 
 613 
 614 
 615 
 616 
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Table 4.  618 
The effect of simulated gastrointestinal digestion on the peptide stability and 619 
antioxidant activity of a Palmaria palmata derived synthetic peptide 620 
 621 
Sample ORAC value 
(nmol TE/µmol 
peptide) 
FRAP value 
(nmol TE/µmol 
peptide) 
Peptide 
sequence 
identified 
Mass 
(m/z) 
z 
SDITRPGGQM  152.43 ± 2.73a 21.23 ± 0.90a SDITRPGGQM 531.2557  2 
SDITRPGGQM - G 144.60 ± 2.56a 21.71 ± 0.52a SDITRPGGQM 531.2571 2 
SDITRPGGQM - GI 125.35 ± 2.04b 2.18  ± 0.07b SDITRPGGQ  465.7358 2 
   SDITRPGG 401.7052 2 
   SDIT 435.2076 1 
   PGGQ 358.1708 1 
   SD 221.0433 1 
   QM 278.1857 1 
   M 150.0593 1 
 622 
G: peptide following simulated gastric digestion, GI: peptide following simulated 623 
gastrointestinal digestion, TE: Trolox equivalents, nd: not determined. Values 624 
represent mean ± SD (n=3). For each peptide and their associated digests values 625 
with different letters are significantly different at p<0.05 626 
 627 
 628 
 629 
 630 
 631 
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 633 
 634 
 635 
 636 
 637 
 638 
 639 
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 642 
 643 
 644 
Figure 1. (a) Semi-preparative reverse phase high performance liquid chromatography 645 
(SP-RP-HPLC) profile of Palmaria palmata aqueous protein hydrolysate solid phase 646 
extraction (SPE) fraction SPE-30% and (b) oxygen radical absorbance capacity (ORAC) 647 
activity of associated fractions (F20-F60). Mean ± SD (n=3). TE: Trolox equivalents, 648 
dw: dry weight. 649 
 650 
 651 
 652 
 653 
 654 
 655 
 656 
 657 
 658 
 659 
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 660 
Figure 2. Mass fragmentation spectrum for the Palmaria palmata derived peptide 661 
SDITRPGGQM (m/z 531.2532). The x-axis represents the m/z at which the precursor 662 
and fragment (b, y) ions were detected. The y-axis shows the relative intensity of ions. 663 
 664 
 665 
